| Date | Time | Source | Headline | Symbol | Company |
| 06/10/2009 | 7:02PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/10/2009 | 6:38PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/10/2009 | 6:38PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/10/2009 | 6:31PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/10/2009 | 6:31PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/10/2009 | 6:30PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/10/2009 | 9:12AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/09/2009 | 6:30AM | Dow Jones News | Doctors Say New Diabetes Drugs Hold Great Promise | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 06/09/2009 | 3:13AM | Dow Jones News | CORRECT: Study: Novo Nordisk's Diabetes Drug Beats Lilly's Byetta | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 06/09/2009 | 3:12AM | Dow Jones News | Novo Nordisk Diabetes Drug Liraglutide Successful In Study | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 06/09/2009 | 3:12AM | Dow Jones News | Study: Novo Nordisk's Diabetes Drug Beats Lilly's Byetta | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 06/08/2009 | 6:45PM | PR Newswire (US) | Meta-Analysis of Clinical Data Showed No Increased Risk of Cardiovascular Events Associated With Exenatide Use: Data Presented a | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/07/2009 | 9:15AM | PR Newswire (US) | Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years: DURATION-1 Interim Lo | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/07/2009 | 9:00AM | PR Newswire (US) | Interim Study Results Presented at ADA 2009: Exenatide Not Associated With Increased Rate of Acute Pancreatitis Compared to Othe | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/06/2009 | 8:00PM | Dow Jones News | UPDATE: Weekly Diabetes Drug Byetta Outdoes Competitors | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 06/06/2009 | 6:30PM | PR Newswire (US) | Use of Mealtime Pramlintide Added to Basal Insulin Showed Similar Improvements in Glycemic Control Compared to Rapid-Acting Insu | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/06/2009 | 3:22PM | Dow Jones News | Study Shows Weekly Byetta Diabetes Drug Outdoes Competitors | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 06/03/2009 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Goldman Sachs Annual Global Health Care Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/03/2009 | 4:06PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/02/2009 | 2:51PM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/02/2009 | 1:59PM | Dow Jones News | UPDATE: Amylin: 2 Dissidents To Replace Chairman, Lead Dir | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 06/02/2009 | 1:36PM | Dow Jones News | Amylin: 2 Dissidents To Replace Chairman, Lead Director | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 06/02/2009 | 12:36PM | PR Newswire (US) | Amylin Announces Preliminary Tabulation of Annual Meeting Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/29/2009 | 8:00AM | PR Newswire (US) | Amylin Pharmaceuticals to Present Compelling Efficacy and Safety Data From Diabetes Programs at ADA 2009 | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/29/2009 | 7:53AM | Marketwired | MaybachFinancial.com Posts Free Analyst Report on HERO, GOOG, EXPD and AMLN | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/27/2009 | 4:37PM | Dow Jones News | UPDATE: Amylin: Dissidents Likely Got Up To Two Board Seats | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 05/27/2009 | 4:05PM | Dow Jones News | Eastbourne Claims Success In Electing Directors To Amylin Board | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 05/27/2009 | 3:32PM | PR Newswire (US) | Amylin Announces Preliminary Results of Annual Meeting of Stockholders | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/27/2009 | 2:19PM | Business Wire | Eastbourne Comments on Election of Directors at Amylin Annual Meeting of Shareholders | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/26/2009 | 6:27PM | PR Newswire (US) | Amylin Advises All Shareholders to Vote Their Blue Proxy Card Today | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |